Our objective was to rigorously evaluate the impact of an antimicrobial stewardship audit-and-feedback intervention, via a stepped-wedge randomized trial. An effective intensive care unit (ICU) audit-and-feedback program was rolled out to 6 non-ICU services in a randomized sequence. The primary outcome was targeted antimicrobial utilization, using a negative binomial regression model to assess the impact of the intervention while accounting for secular and seasonal trends. The intervention was successfully transitioned, with high volumes of orders reviewed, suggestions made, and recommendations accepted. Among patients meeting stewardship review criteria, the intervention was associated with a large reduction in targeted antimicrobial utilization (−21%, P = .004); however, there was no significant change in targeted antibiotic use among all admitted patients (−1.2%, P = .9), and no reductions in overall costs and microbiologic outcomes. An ICU day 3 audit-and-feedback program can be successfully expanded hospital-wide, but broader benefits on non-ICU wards may require interventions earlier in the course of treatment.
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To address concerns of rising bacterial resistance rates due to overuse of antimicrobials [1, 2] and the associated increases in patient morbidity and mortality [3, 4] , the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America published joint guidelines [5] for the development of institutional antimicrobial stewardship programs. In response, our 1200-bed tertiary care teaching hospital initiated a case-by-case audit-and-feedback intervention for patients on their third day of broad-spectrum antibiotics in the intensive care unit. A 1-year follow-up analysis demonstrated that the intervention was associated with a 22% reduction in broad-spectrum antibiotic use, a $95 000 per year cost savings, a 31% reduction in Clostridium difficile infections, and some improvements in Gram-negative bacterial antibiotic resistance rates [6] . These results were consistent with those of a systematic review of stewardship interventions in critically ill patients [7] . However, this review, as well as similar reviews of non-intensive care unit (ICU) stewardship interventions, have indicated that the majority of existing research is susceptible to bias and does not meet the minimum methodologic quality criteria of the Cochrane Collaboration's Effective Practice and Organization of Care Group [8, 9] . As a result, more rigorous evaluations of the impacts of antimicrobial stewardship programs in healthcare systems are required [10] .
An underutilized type of randomized trial that has been gaining popularity is the stepped-wedge design [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] , which involves the randomized and sequential rollout of an intervention to study participants (either individuals or clusters) over time [21] [22] [23] . The stepped-wedge design offers an ethical advantage over traditional randomized trial designs, because all participants receive the intervention by the end of the study. It offers a feasibility advantage, because it overcomes the financial or workload difficulties associated with applying the intervention to many or all participants at once. It offers a statistical advantage in that it can model and adjust for underlying temporal trends [22] . Therefore, to broaden the scope of the antibiotic stewardship program's success, while balancing the need for more rigorous stewardship science, feasibility and ethics, we expanded a successful ICU antimicrobial stewardship prospective audit-and-feedback intervention to several non-ICU services in a stepped-wedge randomized trial.
METHODS

Study Setting and Population
This study was performed at Sunnybrook Health Sciences Centre (SHSC) in Toronto, Ontario, Canada, across the following 6 inpatient services: general internal medicine, nephrology, cardiology, general surgery/trauma, orthopedic surgery, and neurosurgery. Approval was obtained from the SHSC Research Ethics Board.
Study Design: Stepped-Wedge Randomized Trial
The order of implementation of the intervention on the 6 clinical services was determined by random number generation performed by a statistician uninvolved in daily stewardship activities. Following a 6-month control period during which none of the services received antimicrobial stewardship (1 May 2010 to 31 October 2011), the intervention was introduced to each additional service at 1-month intervals, beginning on 1 November 2010. By 1 April 2011, clinical rollout was complete. An additional 12-month data collection period occurred until 30 April 2012, during which all 6 services continued to receive the intervention (Figure 1 ).
Intervention
One week before the antimicrobial stewardship intervention was introduced to each clinical service, an education session was provided at each service's divisional meeting, to introduce the stewardship objectives and intervention details. Feedback was also sought as to how to best tailor the intervention to the division's daily schedule and preferred routes of feedback. All patients admitted to the 6 clinical services and receiving any of the targeted antimicrobial agents were reviewed on days 3 and 10 of therapy. Patients were identified using a locally developed integrated antibiotic stewardship software system [24] . The targeted antimicrobial agents were the carbapenems (ertapenem, meropenem), piperacillin-tazobactam, thirdgeneration cephalosporins (ceftazidime, ceftriaxone), fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin), and intravenous vancomycin. "Nontargeted" antimicrobial agents were defined as all other systemic antimicrobials. "Total" antimicrobial use was defined as the sum of targeted and nontargeted antimicrobials. Appropriateness of antibiotic therapy was assessed by an antimicrobial stewardship pharmacist by chart review; a second antimicrobial stewardship pharmacist was hired to facilitate this hospital rollout of the program. All identified opportunities for optimization of antimicrobial therapy were reviewed with an infectious diseases attending physician for approval or modification. Each suggestion was entered by the stewardship pharmacist into the database to generate an electronic note that was printed and placed in the patients' medical charts. In addition, all approved suggestions for optimization were communicated verbally with the attending services for discussion and feedback. Acceptance or rejections of the stewardship suggestions were recorded in the database. Patients already being followed by the infectious diseases consultation Figure 1 . Timeline of antimicrobial stewardship stepped-wedge rollout to the clinical services. The "stepped" introduction of the intervention occurred over months 7-12; the white "wedge" reflects the control period, and the gray "wedge" the intervention period.
service were excluded from stewardship review. As the antimicrobial stewardship service operated Mondays to Fridays, patients meeting review criteria on a weekend were reviewed either on the preceding Friday or the following Monday.
Outcomes
The primary outcome was the number of days of therapy of targeted antimicrobial therapy per patient-day. Secondary drug outcomes included nontargeted and total antimicrobial utilization (the sum of targeted and nontargeted antimicrobial therapy), measured in days of therapy per 1000 patient-days, and costs of antimicrobial therapy (targeted, nontargeted, and total) per 1000 patient-days. Days of therapy and patient-days were parsed into monthly segments to account for the monthly rollout of the intervention, as one patient's admission could potentially overlap both control and intervention months.
Secondary microbiologic outcomes included infections due to antibiotic-resistant organisms and nosocomial C. difficile infections measured as the number of cases per 1000 patient-days. The following were defined as antibiotic-resistant organisms of interest based on a modified version of the definition by Kluytmans-VandenBergh et al [25] : vancomycin-resistant Enterococcus species; methicillin-resistant Staphylococcus aureus; Enterobacteriaceae when resistant to any extended-spectrum β-lactam or to the fluoroquinolones plus aminoglycosides; and Pseudomonas aeruginosa or Acinetobacter species when resistant to the carbapenems or any 2 of ceftazidime, piperacillintazobactam, fluoroquinolones, and aminoglycosides. The number of nosocomial C. difficile cases was determined prospectively in accordance with Ontario provincial surveillance clinical case definitions [26] . Secondary clinical outcomes included median hospital length of stay and all-cause in-hospital mortality. Process outcomes of the intervention included the number and type of antimicrobial orders reviewed, types of suggestions made, and the percentage of suggestions accepted or rejected.
Data Sources
Patient data including sex, age, admitting clinical service, antimicrobial utilization, patient-days, antibiotic-resistant organisms, hospital length of stay, and mortality were provided by the antimicrobial stewardship database [24] . This database is automatically populated with microbiology, pharmacy, and patient care data for all admitted patients, not just those seen or reviewed by the stewardship service. Nosocomial C. difficile infection data were provided by the institution's Infection Prevention and Control department. Antimicrobial drug acquisition costs were obtained from the institution's pharmacy department.
Statistical Analysis
All outcomes were assessed among 2 cohorts: (1) the cohort of patients qualifying for the stewardship intervention (those receiving at least 3 days of targeted antimicrobial therapy), and (2) all admitted patients on these 6 clinical services.
Patient demographic information in the control and intervention periods were compared using the Student t test or χ 2 test for continuous and categorical data, respectively.
Overall targeted antimicrobial utilization in the control and intervention period were compared using the Wilcoxon signed-rank test (matching by admitting service's overall days of therapy per patient-day count). Within-service targeted antimicrobial utilization in the control and intervention period were compared using the Wilcoxon rank-sum test, where the unit of the analysis was each patient's monthly days of therapy per patient-day count. Negative binomial regression [27] , accounting for clustering at the level of service using random effects as well as for secular and seasonal trends, was used to compare overall targeted antimicrobial utilization in the control and intervention periods for the analysis involving patients qualifying for the stewardship intervention as well as the analysis of all admitted patients. The unit of analysis was each service's mean monthly targeted days of therapy count. The covariates included in these multivariable models were study period, study month (as a continuous variable), and season.
Sensitivity analyses were performed by repeating the primary analysis but removing those patients who crossed from control to intervention period during a single admission, and removing duplicate admissions for patients during the study period.
Secondary drug outcomes (nontargeted, total antimicrobial utilization, and antimicrobial costs) and microbiologic outcomes were aggregated to the level of each service, and the differences between control and intervention periods were compared using the Wilcoxon signed-rank test. All-cause mortality in the control and intervention periods was compared using the χ 2 test. Lengths of stay were compared using the Wilcoxon rank-sum test.
RESULTS
Randomization Order of the Intervention
The randomized order of the monthly rollout of the antimicrobial stewardship service to the clinical services was determined to be neurosurgery (November 2010), orthopedics (December 2010), nephrology (January 2011), general internal medicine (February 2011), cardiology (March 2011), and general surgery/trauma (April 2011).
Patient Characteristics
A total of 19 220 unique patients were admitted to the clinical services during the study period (1 May 2010 to 30 April 2011) and were included in the analysis. These unique patients accounted for a total of 24 520 hospital admissions, and a total of 30 530 monthly admission segments (Figure 2) . Patients in the control and intervention periods were of similar age (median of 68 years in both periods) and sex distribution (55% vs 54% male, P = .1).
Process Outcomes and Uptake of the Intervention
From the start of the antimicrobial stewardship program intervention (1 November 2010) until the end of the study period (30 April 2012), the antimicrobial stewardship pharmacists reviewed a total of 2733 orders prescribed to 1518 unique patients (Table 1 ). This represented 20% of patients admitted to these services during the intervention period. The majority of reviewed orders were on the general internal medicine service (1645/2733 [60%]). Changes to antimicrobial orders were recommended in 47% of cases, with an acceptance rate of 80%. The most frequent recommendation was to discontinue the antimicrobial (53%), followed by a change in route of administration (22%), change in dose (19%), and change in antimicrobial agent (6%).
Targeted Antimicrobial Therapy Utilization
Among patients qualifying for the stewardship intervention, targeted antimicrobial therapy utilization decreased by 14%, from 419 to 360 days of therapy per 1000 patient-days (P = .05); among all admitted patients on these services, targeted antimicrobial therapy utilization decreased by 10%, from 242 to 218 days of therapy per 1000 patient-days (P = .1). Targeted antimicrobial utilization data within each individual clinical service in the control and intervention periods are provided in Table 2 . The greatest reductions were seen in high-use services, including general medicine, and general surgery/trauma. Figure 2 . Total number of patients and patient admissions included in the analysis. Each unique admission was parsed into monthly segments to account for the monthly rollout of the intervention, as one patient's admission could potentially overlap both control and intervention months. a Includes 1199 patients contributing to both control and intervention periods; b Includes 253 admissions contributing to both control and intervention periods.
The negative binomial regression modeling accounting for secular trends and seasonality in antimicrobial utilization demonstrated that the antimicrobial stewardship intervention was associated with a 21% reduction in targeted antimicrobial utilization among patients meeting antimicrobial review criteria (P = .004; Table 3 ). A parallel analysis did not detect an impact of the antimicrobial stewardship intervention on targeted antimicrobial utilization among all admitted patients (−1.2%, P = .9; Table 3 ). The secular trend of antimicrobial utilization was relatively stable (−0.7%, P = .3). Relative to summer, all seasons were associated with a reduction in targeted antimicrobial utilization.
Results of the primary analysis (effect of the intervention on targeted antimicrobial utilization) were robust to the sensitivity analyses performed when patients who crossed over from the control to the intervention period and duplicate admissions were removed (data not shown).
Secondary Outcomes: Nontargeted Drugs, Drug Costs, and Microbiologic and Clinical Outcomes
No significant differences were detected in the use of nontargeted antimicrobials or antimicrobial costs in either the patients qualifying for the stewardship intervention or the overall population of admitted patients. Similarly, the intervention was not associated with a statistically significant change in the incidence of C. difficile or colonization or infection with antimicrobial-resistant organisms. These secondary outcomes are displayed in Table 4 .
DISCUSSION
Our stepped-wedge randomized trial facilitated successful implementation of our stewardship intervention across multiple non-ICU services, with large numbers of antimicrobial orders reviewed, generating large numbers of suggestions for antimicrobial optimization, which were met with high rates of acceptance. There was a large and statistically significant reduction in targeted antimicrobial use among the patients meeting indications for our day 3 audit-and-feedback intervention, in keeping with prior experience in the ICU [6] . Yet, on multivariable analysis our antimicrobial stewardship prospective audit-and-feedback intervention was not associated with significant changes in targeted antimicrobial therapy among all patients admitted to the 6 non-critical care services. As a result, no reductions were seen in nontargeted and total antimicrobial therapy, costs of antimicrobial therapy, nosocomial C. difficile infections, infections due to antimicrobial-resistant organisms, all-cause mortality, and length of stay. Several studies on prospective audit-and-feedback programs have been published [6, [28] [29] [30] [31] [32] [33] [34] [35] [36] ; few have employed a randomized trial design [33] [34] [35] [36] . Some have focused on critically ill patients [35, 36] , whereas others have been conducted in hospital-wide settings [33, 34] . All have demonstrated a reduction in duration of antimicrobial therapy. Of note, Lesprit et al's randomized trial conducted in a hospital-wide study employed a similarly structured prospective audit-and-feedback intervention to our own, and did achieve a significant reduction in duration of antimicrobial therapy [34] . However, a study performed in an oncology ward of a large tertiary care center, although nonrandomized, demonstrated that their prospective-audit-and feedback program targeting the third day of therapy failed to change overall antimicrobial utilization, despite similar suggestion and suggestion acceptance rates to those achieved in our study [32] . Similarly, Cosgrove et al implemented 48-hour postprescription review for medical/surgical patients at 5 tertiary care teaching hospitals, with inconsistent results-a reduction in antimicrobial utilization in 2 hospitals, but either an increase or no significant change in the others [37] .
The large number of antimicrobial orders reviewed and the high suggestion and acceptance rate testify to the excellent functionality of the antimicrobial stewardship day 3 audit-andfeedback program; the efficacy of this program was confirmed by the 21% reduction in targeted antibiotic use among patients qualifying for the intervention. The lack of significant impact among overall admitted patients on these wards suggests that the overall impacts of the intervention were diluted by the higher prevalence of abbreviated antibiotic courses on these noncritical care wards. In particular, the shorter length of stay of ward patients (median of 4 days) may have limited the impact of our day 3 intervention on inpatient antimicrobial utilization. Although Lesprit et al's similar intervention significantly reduced antimicrobial utilization, the median length of stay of their target population was much longer (15 days) [34] . We speculate that the outpatient postdischarge portion of antimicrobial treatment courses were most impacted by our intervention. Unfortunately, outpatient prescriptions were not captured in the data, so we were unable to confirm this hypothesis. However, this theory is supported by the more significant reduction in targeted antimicrobial utilization attained in those patients meeting antimicrobial stewardship review criteria, where a 21% reduction was attained (P = .004). In this subset of patients, the median length of stay was more than twice as long (approximately 10 days), providing a larger window of opportunity for the intervention to have an impact on inpatient antimicrobial use. A major strength of the study was its large sample size. Included in the analyses were data pertaining to 19 220 patients admitted to the hospital over the 2-year study period. The stepped-wedge design made it possible for the antimicrobial stewardship team to undertake the high workload associated with expanding the intervention to the many clinical services, and provided a way to ethically study the effects of the intervention; more important, however, it also enabled a much more rigorous analysis of the effect of the intervention by taking into account preexisting seasonal and secular trends in antibiotic utilization that may confound results. In this manner, the study improves upon much of the existing literature around the effectiveness of antimicrobial stewardship interventions.
A significant limitation of the study was that the inpatient data sets do not capture outpatient ( postdischarge) antimicrobial therapy, such that we may be missing a very important societal benefit of this intervention on postdischarge antibiotic use and downstream antibiotic-related sequelae. However, the main programmatic objective is to achieve reductions in inpatient antimicrobial use to reduce antibiotic costs and complications within the funding institution. Even if substantial reductions in postdischarge antibiotic use were achieved, this would not translate to reduced hospital drug costs, nor would it reduce antimicrobial drug resistance or C. difficile infections within the institution. Additionally, at the time of the study, our institution already had an ongoing audit-and-feedback program in critical care [6] , as well as several other long-standing hospital-wide stewardship interventions (eg, antimicrobial formulary and handbook, carbapenem restriction, active infectious diseases consultation service) which may have reduced baseline rates of antimicrobial utilization and lowered the ceiling of the potential impact of our new intervention. Although the study sample size was large, there were few microbiologic events (C. difficile infections and infections due to antibiotic-resistant organisms), possibly underpowering the analysis to detect any potential changes. Additionally, a 2-year study period may not have afforded an adequate time frame to detect changes in these outcomes.
A prospective audit-and-feedback antibiotic stewardship intervention was successfully transitioned from the critical care to non-critical care settings across the hospital in a stepped-wedge randomized trial design that blended ethical and feasible implementation with increased statistical rigor. The intervention was well received, and had a substantial and significant impact on antimicrobial utilization in its target population. However, there was no significant effect on overall targeted antimicrobial utilization among all admitted patients on these wards, perhaps due to short admission lengths in these non-critical care settings, such that many recipients of these drugs did not qualify for intervention. Without a reduction in overall or targeted antimicrobial utilization, there were no reductions in hospital drug acquisition costs, antimicrobial resistance rates, or C. difficile infection. Consideration of the patient characteristics and length of stay is therefore warranted when planning the timing and nature of antimicrobial audit-andfeedback interventions. To strengthen antimicrobial stewardship's impact in non-critical care settings, future work may involve targeting antimicrobial utilization earlier in the course of therapy. 
Notes
